logo-loader
Bio-Gene Technology Ltd

Bio-Gene Technology talking with potential partners worldwide about next-gen insecticides

Bio-Gene Technology Ltd (ASX:BGT) CEO & MD Richard Jagger introduces Proactive Investors to the Aussie company producing next generation insecticides, both natural and synthesised, and the global opportunities in agriculture and public health.

"As an industry we're always trying to move towards safer chemistry - what we might call softer chemistry - that works better in harmony with the environment, and can target the pests that are perhaps becoming resistant to other chemistry that's being used," explains Jagger.

He goes on to detail the latest on the company's Flavocide and Qcide products, as well as upcoming milestones.

Quick facts: Bio-Gene Technology Ltd

Price: $0.19

Market: ASX
Market Cap: $24.51 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Northern Minerals reveals talks with US government agencies,...

Northern Minerals Ltd (ASX:NTU) CEO George Bauk tells Proactive he recently met US government agencies, who he says wanted to get a better sense of the Australian company's progress with its dysprosium production, and its strategy going forward. Bauk is currently in New York meeting with...

2 days, 9 hours ago

2 min read